Objective:To discuss the relationship between Bax expression level and lung cancer cell apoptosis induced by peroxisome proliferator-activated receptor-γ(PPAR-γ) agonists.Methods:RT-PCR and Western blot analyis were...Objective:To discuss the relationship between Bax expression level and lung cancer cell apoptosis induced by peroxisome proliferator-activated receptor-γ(PPAR-γ) agonists.Methods:RT-PCR and Western blot analyis were used to detect PPAR-γ expression in the lung cancer cells,and TUNEL was used to detect apoptosis induced by PPAR-γ agnoists,while in situ hybridization and immunohistochemistry were used to monitor the changes of Bax mRNA and protein expression levels after apoptosis induced.Results PPAR-γ expression was detectable in two kinds lung cancer cells (including Non-small cell lung cancer and small cell lung cancer) ,and PPAR-γ agonists could inhibit lung cancer growth through inducing apoptosis.The apoptostic rates in control group,15d-PGJ2 group and cilitazone group were (1.86±0.49)%,(25.8±2.9)±,and (17.3±1.9)%,(P<0.01)respectively;Bax mRNA expression rates in the three groups were (8.75± 1.36)%,(66.2±12.86)%,and(29.5±6.5)%(P<0.01)respectively;Bax protein expression rates in the three groups were(9.2±1.45)%,(63±10.4)%,and (34.5±6.0)%(P<0.05) respectively.Conclusion PPAR-y is predicted to be a new targes in treating lung cancer in the future,and Bax is most likely to work in treating lung cancer apoptosis induced by PPAR-y agnoists as a factor to induce apoptosis.展开更多
文摘Objective:To discuss the relationship between Bax expression level and lung cancer cell apoptosis induced by peroxisome proliferator-activated receptor-γ(PPAR-γ) agonists.Methods:RT-PCR and Western blot analyis were used to detect PPAR-γ expression in the lung cancer cells,and TUNEL was used to detect apoptosis induced by PPAR-γ agnoists,while in situ hybridization and immunohistochemistry were used to monitor the changes of Bax mRNA and protein expression levels after apoptosis induced.Results PPAR-γ expression was detectable in two kinds lung cancer cells (including Non-small cell lung cancer and small cell lung cancer) ,and PPAR-γ agonists could inhibit lung cancer growth through inducing apoptosis.The apoptostic rates in control group,15d-PGJ2 group and cilitazone group were (1.86±0.49)%,(25.8±2.9)±,and (17.3±1.9)%,(P<0.01)respectively;Bax mRNA expression rates in the three groups were (8.75± 1.36)%,(66.2±12.86)%,and(29.5±6.5)%(P<0.01)respectively;Bax protein expression rates in the three groups were(9.2±1.45)%,(63±10.4)%,and (34.5±6.0)%(P<0.05) respectively.Conclusion PPAR-y is predicted to be a new targes in treating lung cancer in the future,and Bax is most likely to work in treating lung cancer apoptosis induced by PPAR-y agnoists as a factor to induce apoptosis.